Table 4.
Time frame/Measure | Model 1 | Model 2 | Model 3 | Model 4 |
---|---|---|---|---|
Year 1 | ||||
AUC | 0.94 (0.02) | 0.97 (0.01) | 0.96 (0.01) | 0.97 (0.01) |
PE(×10) | 0.10 (<0.01) | 0.09 (0.01) | 0.09 (0.01) | 0.09 (0.01) |
PCF(0.1) | 0.87 (0.03) | 0.91 (0.03) | 0.89 (0.03) | 0.90 (0.03) |
PCF(0.2) | 0.92 (0.03) | 0.97 (0.02) | 0.95 (0.02) | 0.98 (0.02) |
PNF(0.8) | 0.06 (0.04) | 0.05 (0.02) | 0.05 (0.02) | 0.04 (0.02) |
PNF(0.9) | 0.14 (0.09) | 0.09 (0.05) | 0.11 (0.04) | 0.10 (0.04) |
Year 3 | ||||
AUC | 0.89 (0.01) | 0.94 (0.01) | 0.94 (0.01) | 0.95 (0.01) |
PE(×10) | 0.26 (0.01) | 0.23 (0.02) | 0.22 (0.03) | 0.21 (0.03) |
PCF(0.1) | 0.69 (0.02) | 0.83 (0.02) | 0.82 (0.02) | 0.86 (0.02) |
PCF(0.2) | 0.83 (0.02) | 0.91 (0.02) | 0.92 (0.02) | 0.93 (0.02) |
PNF(0.8) | 0.18 (0.04) | 0.08 (0.02) | 0.09 (0.02) | 0.08 (0.01) |
PNF(0.9) | 0.35 (0.05) | 0.17 (0.04) | 0.18 (0.04) | 0.14 (0.04) |
Year 5 | ||||
AUC | 0.85 (0.01) | 0.92 (0.01) | 0.93 (0.01) | 0.94 (0.01) |
PE(×10) | 0.46 (0.03) | 0.40 (0.04) | 0.39 (0.05) | 0.38 (0.05) |
PCF(0.1) | 0.57 (0.02) | 0.74 (0.02) | 0.76 (0.02) | 0.77 (0.02) |
PCF(0.2) | 0.74 (0.02) | 0.86 (0.02) | 0.87 (0.02) | 0.89 (0.02) |
PNF(0.8) | 0.27 (0.03) | 0.13 (0.02) | 0.13 (0.02) | 0.12 (0.02) |
PNF(0.9) | 0.51 (0.04) | 0.24 (0.04) | 0.23 (0.04) | 0.21 (0.03) |
Model 1: adjusted for age, sex, race/ethnicity, and eGFR. Model 2: model 1 covariates plus dipstick proteinuria and an interaction between eGFR and dipstick proteinuria. Model 3: model 2 covariates plus health insurance coverage and comorbidities (diabetes mellitus, cardiovascular disease, hypertension, substance abuse, and chronic viral disease). Model 4: model 3 covariates plus additional laboratory variables (serum albumin, calcium, hemoglobin, and cholesterol). AUC, area under the ROC curve; PE (×10), prediction error multiplied by a factor of 10.